[Inhibitory effects of Na2SeO3 on Tca8113 cells in vitro and in vivo]
1Gengeral Hospital of PLA, Beijing.
Abstract:
In the study, Na2SeO3 effectively limited the growth and proliferation of Tca8113 cells both in vitro and in vivo. The response was dependent on the dose, the starting administered time, exposed length of selenium and density of inoculated Tca8113 cells. At 1 microgram/ml dose of selenium, there were remarkable inhibitory effects while no detectable inhibitory effect to L929 cells. 1 microgram/ml dose for less than 24 hours, the growth and proliferative ability of Tca8113 cells was reversal whereas more than that period, was irreversal. In vivo experiment, the morbidity of transplanted tumors was remarkably depressed with Se-intraperitoneal injection. At 60 micrograms/ip dose, the weight of nude mice were not reduced and the pathological changes in liver and kidney had not found.
Insights
Sodium selenite (Na2SeO3) demonstrated significant anti-cancer effects against Tca8113 cells in vitro and in vivo. The study highlights its potential as a targeted therapeutic agent with minimal toxicity to normal cells.
Area of Science:
- Oncology
- Cell Biology
- Toxicology
Context:
- Thyroid cancer research
- Investigating novel anti-cancer agents
- In vitro and in vivo cancer models
Purpose:
- To evaluate the efficacy of sodium selenite (Na2SeO3) in inhibiting Tca8113 cell growth and proliferation.
- To determine the dose-dependency and time-dependency of Na2SeO3's anti-cancer effects.
- To assess the safety and toxicity profile of Na2SeO3 in normal cells and animal models.
Summary:
- Sodium selenite (Na2SeO3) significantly inhibited Tca8113 cell growth and proliferation in vitro and in vivo.
- A dose of 1 microgram/ml of selenium showed remarkable inhibitory effects on Tca8113 cells, with no detectable effect on L929 cells.
- Reversible inhibition of Tca8113 cells occurred with exposure less than 24 hours, while longer exposure led to irreversible effects. Intraperitoneal injection in nude mice suppressed tumor growth without causing adverse effects on body weight or major organs.
Impact:
- Provides evidence for the potential therapeutic application of sodium selenite in treating Tca8113-related cancers.
- Establishes optimal dosage and exposure parameters for Na2SeO3's anti-cancer activity.
- Suggests a favorable safety profile for Na2SeO3, warranting further clinical investigation.
More Related Videos
10:05In Vitro Multiparametric Cellular Analysis by Micro Organic Charge-modulated Field-effect Transistor Arrays
Published on: September 20, 2021
10:01High-Throughput Optical Controlling and Recording Calcium Signal in iPSC-Derived Cardiomyocytes for Toxicity Testing and Phenotypic Drug Screening
Published on: March 31, 2022